Timing of RRT based on the presence of conventional indications. - Wikidata - wikimedia - TriplyDB

Timing of RRT based on the presence of conventional indications.

Timing of RRT based on the presence of conventional indications.

http://www.wikidata.org/entity/Q34124792

about

Renal Replacement Therapy Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Trends in One-Year Outcomes of Dialysis-Requiring Acute Kidney Injury in Denmark 2005-2012: A Population-Based Nationwide Study.Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial Renal replacement therapy practices for patients with acute kidney injury in China.Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.Prevention and treatment of sepsis-induced acute kidney injury: an update.The future of critical care: renal support in 2027.A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI.Volume-related weight gain as an independent indication for renal replacement therapy in the intensive care units.Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.Importance of RIFLE (Risk, Injury, Failure, Loss, and End-Stage Renal Failure) and AKIN (Acute Kidney Injury Network) in Hemodialysis Initiation and Intensive Care Unit Mortality A policy of preemption: the timing of renal replacement therapy in AKI.High-Volume Hemofiltration in Post-Cardiac Surgery Shock. A Heroic Therapy?The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience.Optimal Role of the Nephrologist in the Intensive Care Unit.Does this patient with AKI need RRT?The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation.Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels.Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.Sex differences in acute kidney injury requiring dialysis.Biomarkers for AKI improve clinical practice: yes

P2860

Q26766116-06F4A797-7E84-4ECE-9372-FD3A7F1B3FE2 Q30234560-C58B3692-47DD-4905-92A0-4F09722FE140 Q36085952-4CCB30F9-C714-474E-9F59-722B9C156B9A Q37148514-22BC938B-5719-4F22-B669-7007AC081236 Q38660210-82360091-7F55-4DD7-9150-F4FE883AFF5E Q38665661-7C3334C3-124C-4D1F-8209-F8A4C8F6AAE1 Q38675436-034BE6D1-E9F6-4581-85A4-15251D01E601 Q38732351-B388A873-9A9A-4743-96C6-6BFF1F225FA3 Q39001160-E7F13C73-8123-4F9B-ADC6-7BE2500014FE Q39294708-8EE62454-89B7-48D1-A2AD-CCC2F06DFF7B Q39711048-CB1A2053-989B-48A5-B120-8B38E6988C3D Q41098373-DBC66CF8-45E7-4F84-B6EA-63F517E7D5BC Q42858169-6A315E80-E982-497D-953F-6B78D009DB8F Q45392632-029BFFA4-4E49-4F24-B634-331A5D259E15 Q47110248-0D97383A-3B92-48B9-8762-52854C79B7EB Q47171707-00EB6BD8-09FC-4512-9F85-651567E2A5B1 Q47613094-32EEDABB-F64B-4E5B-8BF7-04E6B9825120 Q47738464-0114A46E-19F5-4513-B6E8-8907571ED82E Q49565460-D6E4CEDD-E9B6-4D47-8065-9BB7EE0DBD11 Q55069271-D8EF767A-85D4-4A83-AEC4-4BBB0EB1CEA4 Q55261185-2C752647-74E4-4CCD-9168-253BACE2D36D Q56967976-76C05AA9-DE29-49C7-82CB-043E0E4BFE72

P2860

Timing of RRT based on the presence of conventional indications.

http://www.wikidata.org/entity/Q34124792

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Timing of RRT based on the presence of conventional indications.

@ast

Timing of RRT based on the presence of conventional indications.

@en

Timing of RRT based on the presence of conventional indications.

@nl

type

label

Timing of RRT based on the presence of conventional indications.

@ast

Timing of RRT based on the presence of conventional indications.

@en

Timing of RRT based on the presence of conventional indications.

@nl

prefLabel

Timing of RRT based on the presence of conventional indications.

@ast

Timing of RRT based on the presence of conventional indications.

@en

Timing of RRT based on the presence of conventional indications.

@nl

P1433

Q34124792-D9E0E88B-1A3C-4F6D-A3A2-11FB14B26854

P1476

Q34124792-D605688E-40D0-4194-B891-46ED954941D2

P2093

Q34124792-1AA376BA-6977-4CD7-B0BC-1233E8C3278D

Q34124792-1B289276-4EA5-4B1B-AC2A-5F8116664AB0

Q34124792-5C9D642E-FE07-4DD4-85F9-2A958772D687

Q34124792-6FB84FAC-BCCC-4CFE-B52A-975336B7C94F

Q34124792-CC9F3BA5-5215-4535-A140-3755BB8285AD

Q34124792-F50C5C17-51A3-4EB8-B862-5F2AE1B0DF40

P2860

Q34124792-0D0D7255-3554-4D56-83CB-56FB62FC6EF3

Q34124792-0E7F1B86-7D5C-4CF8-9E85-648BA311F911

Q34124792-2C641073-BE9D-4002-BEC4-FFCFC195E49D

Q34124792-2CACC798-8611-430E-9E3D-077496F0C038

Q34124792-36B587B9-B920-42E0-8537-6BDA56315A31

Q34124792-3BF3459D-8F4C-40AE-B60B-6703DF87F28C

Q34124792-3E471067-1E3C-43FF-9A38-9A9B2A398690

Q34124792-44F3F48C-0368-48E8-95CA-12256314EA84

Q34124792-658F1C32-C1C3-4D36-B5D1-D6CE0C78C771

Q34124792-716EC4A9-31AC-4359-88BD-400CBD8E30CA

P304

Q34124792-FBBFE04D-DC00-4CDB-B089-5BB568703630

P31

Q34124792-C4D95A31-1D92-43F2-B8A7-7A540B1A0651

P356

Q34124792-AC92C189-9BEA-43E3-BA68-23A4460E8E27

P433

Q34124792-E70A6AA6-071A-4B1B-B4D5-35769B317182

P478

Q34124792-B1CDB51C-37B9-4DB3-849D-1FBBBD6D1897

P577

Q34124792-989CDD16-B003-4382-A91E-59DF72135840

P698

Q34124792-ACFB7EEF-5383-4981-9E4A-BE3E87134268

P932

Q34124792-22D2E417-7DC1-4C56-8FB0-1E96C4065C40

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Timing of RRT based on the presence of conventional indications.

@en

P2093

FINNAKI Study Group

http://www.w3.org/2001/XMLSchema#string

Matti Reinikainen

http://www.w3.org/2001/XMLSchema#string

Ron Wald

http://www.w3.org/2001/XMLSchema#string

Sean M Bagshaw

http://www.w3.org/2001/XMLSchema#string

Suvi T Vaara

http://www.w3.org/2001/XMLSchema#string

Ville Pettilä

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Intensity of renal support in critically ill patients with acute kidney injury.

Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study.

Improved confidence intervals for the difference between binomial proportions based on paired data.

Timing of renal replacement therapy initiation by AKIN classification system.

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Chronic dialysis and death among survivors of acute kidney injury requiring dialysis.

Intensity of continuous renal-replacement therapy in critically ill patients.

Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury

Population-based incidence, mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in Finnish intensive care units.

P304

1577-1585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.12691213

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25107952

http://www.w3.org/2001/XMLSchema#string

P932

4152821

http://www.w3.org/2001/XMLSchema#string